Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 5 | Cell & Bioscience

Fig. 5

From: Transcriptomics, lipidomics, and single-nucleus RNA sequencing integration: exploring sphingolipids in MASH-HCC progression

Fig. 5

Ceramide composition and levels in the liver during MASH-HCC disease progression in DIAMOND mice. Liver tissues were processed for ceramide profiles using LC-MS/MS. (A) Pie charts showing the ceramide (Cer) composition profile in the liver from different groups expressed as a percentage of total Cer. (B) Levels of different types of Cers in the liver. Data are expressed as the mean ± SEM. Statistical significance relative to the corresponding CDNW group: *p < 0.05, ***p < 0.001. Statistical significance relative to CDNW-6 M or WDSW-6 M group: #p < 0.05, ##p < 0.01 (n = 10–15)

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us